# US 5,891,233 A · Use of bioactive silicious glass and new compositions containing bioactive silicious glass

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 5,891,233 A
- Document ID: US5891233A
- Status: Granted
- Kind: A
- Application number: 08/809,867
- Filed: 1997-04-02
- Granted: 1999-04-06
- Earliest claimed: 1994-10-06
- Assignees: Bioxid Oy
- Inventors: Jukka Salonen; Ulla Tuominen; Antti Yli-Urpo
- Web page: https://patentgrep.com/patent/US5891233A

## CPC

- A61K 6/17: Particle size
- A61K 6/30: Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
- A61K 6/54: Filling; Sealing
- A61K 6/807: comprising magnesium oxide
- A61K 6/816: comprising titanium oxide
- A61K 6/836: Glass
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A pharmaceutical preparation, including a glass phase which is bioactive silica containing glass in the form of a paste, suspension or solution mixed in a physiologically suitable liquid or bound to a physiologically suitable vehicle, and which preparation reduces the pulpal irritation or a tooth and/or strengthens the structure of a tooth. Bioactive silica containing glass may be a material which contains only Si-oxide or Si-hydroxide and which allows the formation and movement of Si--OH-groups. Preferably, the preparation also contains calcium and phosphate sources.

## Claims

### Claim 1

A method of treatment of a person suffering from pulpal irritation and/or in need of strengthening his tooth structure, comprising treating at least one tooth of said person with a preparation consisting essentially of bioactive silica containing glass, wherein said preparation is capable of rapid release of silica in a concentration effective to induce crystallization of apatite in dental tubules and/or on the tooth surface.

### Claim 2 (depends on 1)

The method of claim 1, wherein said bioactive silica containing glass is in the form of a powder suspended in a physiologically acceptable liquid, or is bound to a physiologically acceptable binder selected from the group consisting of fibrinogen and chitin.

### Claim 3 (depends on 1)

The method of claim 1, wherein said bioactive silica containing glass further comprises calcium and phosphate ions, or said preparation further consists essentially of calcium and phosphate providing sources.

### Claim 4 (depends on 1)

The method of claim 1, wherein said preparation has a pH equal to or greater than 9.5.

### Claim 5 (depends on 1)

The method of claim 1, wherein said crystallization of apatite in dental tubules and/or on the tooth surface occurs within about one week.

### Claim 6

A pharmaceutical preparation suitable for reducing pulpal irritation and/or strengthening the structure of a tooth, consisting essentially of a glass phase containing bioactive silica containing glass, wherein
said preparation is sufficiently moist to maintain chemical interactions between the glass phase and dentine so as to permit transfer of silica into dentine, and
said bioactive silica containing glass is present in an amount which renders said preparation capable of rapid release of silica in a concentration effective to induce crystallization of apatite in dental tubules and/or on the tooth surface.

### Claim 7 (depends on 6)

The preparation of claim 6, wherein said preparation has a pH equal to or greater than 9.5.

### Claim 8 (depends on 6)

The preparation according to claim 6, further consisting essentially of calcium and phosphate sources.

### Claim 9 (depends on 6)

The preparation according to claim 6, wherein said preparation further consists essentially of an agent for promoting the growth of crystals in the dentine tissue.

### Claim 10 (depends on 6)

The preparation according to claim 6, wherein the glass phase is solely Si-oxide or Si-hydroxide, or comprises in addition to Si-oxide or Si-hydroxide, at least one member of the group consisting of Na, K, Ca, Mg, B, Ti, Al, P, N and F, or is a solution comprising Si--OH groups.

### Claim 11 (depends on 10)

The preparation of claim 10, wherein the composition of the glass phase is as follows:
______________________________________ SiO.sub.2 or Si-gel 1-100% CaO 0-40% P.sub.2 O.sub.5 0-60% Na.sub.2 O 0-45% K.sub.2 O 0-45% MgO 0-40%. ______________________________________

### Claim 12 (depends on 10)

The preparation of claim 10, wherein the composition of the glass phase is as follows: SiO.sub.2 53%; CaO 20%; P.sub.2 O.sub.5 4% and Na.sub.2 O 23%.

### Claim 13 (depends on 10)

The preparation of claim 10, wherein the composition of the glass phase is as follows: SiO.sub.2 45%; CaO 22%; P.sub.2 O.sub.5 7%; Na.sub.2 O 24% and B.sub.2 O.sub.3 2%.

### Claim 14 (depends on 6)

The preparation of claim 6, wherein the preparation further consists essentially of ceramic powder.

### Claim 15 (depends on 1)

The preparation according to claim 1, wherein said physiologically suitable binder is fibrinogen or chitin.

### Claim 16 (depends on 8)

The preparation according to claim 8, wherein the glass phase is solely Si-oxide or Si-hydroxide, or comprises in addition to Si-oxide or Si-hydroxide at least one member of the group consisting of Na, K, Ca, Mg, B, Ti, Al, P, N and F, or is a solution comprising Si--OH groups.

### Claim 17 (depends on 9)

The preparation according to claim 9, wherein the glass phase is solely Si-oxide or Si-hydroxide, or comprises in addition to Si-oxide or Si-hydroxide, at least one member of the group consisting of Na, K, Ca, Mg, B, Ti, Al, P, N and F, or is a solution comprising Si--OH groups.

### Claim 18 (depends on 10)

The preparation according to claim 10, wherein said glass phase is silica gel.

### Claim 19 (depends on 16)

The preparation according to claim 16, wherein said glass phase is silica gel.

### Claim 20 (depends on 17)

The preparation according to claim 17, wherein said glass phase is silica gel.
